Article
RhoA activation-mediated vascular permeability in capillary malformation-arteriovenous malformation syndrome: a hypothesis.
Drug discovery today - 1 Aug 2021
Eisa-Beygi Shahram, Vo Nghia Jack, Link Brian A
Abstract excerpt
Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is a class of capillary anomalies that are associated with arteriovenous malformations and arteriovenous fistulas, which carry a risk of hemorrhages. There are no broadly effective pharmacological therapies currently available. Most CM-AVMs are associated with a loss of RASA1, resulting in constitutive activation of RAS signaling. However,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
